Cite
HARVARD Citation
Lepir, T. et al. (2019). Nivolumab to pembrolizumab switch induced a durable melanoma response. Medicine. 98 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lepir, T. et al. (2019). Nivolumab to pembrolizumab switch induced a durable melanoma response. Medicine. 98 (2), p. . [Online].